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Abstract: Genetics play an important role in the development of metabolic diseases. However, the
relative influence of genetic variation on metabolism is not well defined, particularly in tissues,
where metabolic dysfunction that leads to disease occurs. We used inbred strains of laboratory mice
to evaluate the impact of genetic variation on the metabolomes of tissues that play central roles
in metabolic diseases. We chose a set of four common inbred strains that have different levels of
susceptibility to obesity, insulin resistance, and other common metabolic disorders. At the ages
used, and under standard husbandry conditions, these lines are not overtly diseased. Using global
metabolomics profiling, we evaluated water-soluble metabolites in liver, skeletal muscle, and adipose
from A/J, C57BL/6J, FVB/NJ, and NOD/ShiLtJ mice fed a standard mouse chow diet. We included
both males and females to assess the relative influence of strain, sex, and strain-by-sex interactions
on metabolomes. The mice were also phenotyped for systems level traits related to metabolism and
energy expenditure. Strain explained more variation in the metabolite profile than did sex or its
interaction with strain across each of the tissues, especially in liver. Purine and pyrimidine metabolism
and pathways related to amino acid metabolism were identified as pathways that discriminated
strains across all three tissues. Based on the results from ANOVA, sex and sex-by-strain interaction
had modest influence on metabolomes relative to strain, suggesting that the tissue metabolome
remains largely stable across sexes consuming the same diet. Our data indicate that genetic variation
exerts a fundamental influence on tissue metabolism.
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1. Introduction
Metabolic phenotypes such as body composition and energy expenditure vary widely
among individuals within a population. This variation contributes to the ability to maintain
a healthy body weight, and to the long-term risk of metabolic diseases such as obesity
and type 2 diabetes (T2D). Genetic background is a major contributor to inter-individual
differences in metabolic traits. For example, large-scale studies of twins estimate the genetic
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contribution to variation in body mass index, which is widely used to assess obesity, to be
as high as 85% [1].
Fundamental differences in metabolism at the cellular level contribute to variation
in metabolic phenotypes between individuals. Metabolomics has emerged as a valuable
platform for querying cellular metabolism and efficiently quantifying large sets of metabolites in experimental and clinical samples. Some classes of metabolites are thought to
be highly heritable [2,3]. Accordingly, specific metabolite profiles have been linked to
genetic susceptibility to disease studies in large-scale GWAS studies [4,5]. Nonetheless,
population structure, rare variants, and non-genetic, unmeasured differences in diet, environment, and lifestyle complicate efforts to delineate the influence of genetic background on
metabolomes in humans [6]. Understanding how genetic background influences metabolic
profiles is important for precision medicine and for tailoring pharmacological treatments
to the individual [2]. This insight is particularly relevant for developing strategies to
improve metabolic health through precision nutrition and for targeted diet to optimize
metabolic health [7].
Inbred strains of laboratory mice are a valuable set of models with which to understand
the influence of genetic background on metabolism. Inbreeding allows genetic replicability,
and laboratory husbandry provides the ability to control the diet and environment. Although mice and humans differ, many aspects of metabolism are shared between the two
species. In addition, mice allow metabolomes to be profiled at the tissue level, where the
underlying inputs to organismal level metabolic differences arise. Here, we utilize this control to evaluate the impact of both genetic background and sex on tissue metabolomes. We
used untargeted metabolomics to quantify metabolites in three key metabolic tissues (adipose, liver, and skeletal muscle) from four common inbred strains of mice (A/J, C57BL/6J,
FVB/NJ, and NOD/ShiLtJ) maintained under the same diet and husbandry conditions,
and of the same age. Like individuals in a population, these strains represent varying levels
of adiposity, metabolic health, and response to common human-relevant diets, and the
variation in these traits differs between males and females. For example, A/J mice are
relatively resistant to diabetes and obesity, while C57BL/6J mice are susceptible to these
same disorders [8–11]. NOD/ShiLtJ mice are prone to developing type 1 diabetes [12].
FVB/NJ mice have high rates of activity, but are genetically prone to certain cancers and to
anxiety [13,14]. Male and female mice were phenotyped for metabolic rate and their body
composition and metabotyped for the effects of strain, sex, and their interactions. Tissue
metabolite profiles were associated with system level markers of energy expenditure and
body composition. Collectively, we report that genetic background has a major influence
on tissue metabolomes.
2. Results
2.1. Physiological Measurements Reveal Differences among Strain and Sex-by-Strain
Body composition and indirect calorimetry were used to quantify the effects of sex
and strain on key system-level metabolic phenotypes. Males were heavier than females,
regardless of strain (Figure 1A). Body weight did not differ significantly between strains,
and relatively modest effects of an interaction between sex and strain (p = 0.052) were
observed for weight (Table 1). The relative weight of adipose tissue (adiposity) varied
significantly between strains in a manner that was influenced by sex. For example, A/J
mice were the fattest of the females, with adiposity levels approximately twice those of
the other three strains, while C57Bl/6J was the fattest strain for male mice (Figure 1B).
Interactions between sex and strain also significantly influenced oxygen consumption (VO2 ;
p = 0.023) and heat output (p < 0.001) (Table 1). VO2 , an indirect measurement of energy
expenditure, was lowest in A/J mice of both sexes (Figure 1C). Heat output was also lowest
in A/J mice among females (Figure 1E). C57Bl/6J females produced significantly more
metabolic heat than the other strains, but heat production in C57Bl/6J was relatively low
in male mice. Activity level was not influenced by the interaction between sex and strain,
but was significantly affected by each parameter independently (Table 1). Females had

was not significantly affected by sex, strain, or sex-by-strain, which was expected given
that all strains were fed the same diet (Figure 1D). Collectively, these results confirm that
both sex and genetic variation influence important physiological traits that are relevant to
metabolism in this set of inbred strains.
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Sex
Strain
Sex-by-Strain
Weight
<0.001
0.284
0.052
Adiposity
0.338
<0.001
0.015
significantly higher levels of activity, while C57BL/6J mice had the highest levels of activity
2
<0.001 exchange ratio 0.023
relative to all VO
other
strains (Figure0.001
1F). The respiratory
was not significantly
RER
0.148
affected by sex, strain, or sex-by-strain, which 0.594
was expected given 0.100
that all strains were
Heatdiet
Output
<0.001
fed the same
(Figure 1D). Collectively,
these0.001
results confirm that<0.001
both sex and genetic
Activity
0.009
0.020
0.124
variation influence important physiological traits that are relevant to metabolism
in this set
p < 0.05 is considered significant.

of inbred strains.
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Table 1. p-values for effects of sex, strain, and sex-by-strain interaction on weight and metabolism.

Weight
Adiposity
VO2
RER
Heat Output
Activity

Sex

Strain

Sex-by-Strain

<0.001
0.338
0.001
0.148
<0.001
0.009

0.284
<0.001
<0.001
0.594
0.001
0.020

0.052
0.015
0.023
0.100
<0.001
0.124

p < 0.05 is considered significant.

2.2. Significant Effects of Strain, Sex and Their Interactions on Tissue Metabolomes
Liver, skeletal muscle, and adipose tissue are fundamental to systemic energy balance
and metabolic health. Global metabolomic profiling of these tissues was used to characterize
the effects of sex and strain on tissue metabolism. A total of 167 identified metabolites
(those for which m/z and retention time have been matched to standards in our library)
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Figure 2. Relative impact of sex, strain, and sex-by-strain interactions on tissue metabolomes.
(A) The number of metabolites that differed significantly by strain, based on ANOVA (FDR < 0.05),
across tissues. The number of metabolites that differed significantly by sex, strain, and sex-by-strain
interaction in (B) adipose, (C) muscle, and (D) liver.
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Sixty-five, fifty-five, and sixty-nine known metabolites had a VIP > 1 in adipose, muscle,
and liver, respectively. The overlap between these three subsets showed that 16, 28, and
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Figure 5. Strain-specific differences in purine metabolite levels in adipose and liver tissue. MeFigure
5. Strain-specific differences in purine metabolite levels in adipose and liver tissue.
tabolites that differed significantly between strains in adipose and/or liver were mapped onto the
Metabolites
that differed
between
strains
in adipose
and/or liver
mapped
purine KEGG
pathway.significantly
Significant differences
between
strains
were determined
using were
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and onto
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KEGG
pathway.
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sample +/− standard error. The y-axis represents the abundance of the metabolite in arbitrary units.
The x-axis represents each strain, which is color-coded and listed in the legend. Connections between
metabolites indicated by arrows are based on the purine KEGG pathway. Dashed lines represent
missing metabolites in the pathway. Data for adipose or liver are only shown if strain significantly
affected metabolite abundance. Horizontal bars represent pairwise comparisons performed using
Tukey’s HSD post hoc analysis; * p < 0.05, ** p < 0.01, and *** p < 0.001.
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Table 2. KEGG pathway enrichment of metabolites affected by sex, strain, and sex-by-strain.
Tissue

Factor

Pathway

Hits

p-Value

(i/m)q

All Tissues

Sex

Purine metabolism

9

<0.001

0.001

Strain

Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Ascorbate and aldarate metabolism
Citrate cycle (TCA cycle)
Pantothenate and CoA biosynthesis
Aminoacyl-tRNA biosynthesis

20
15
8
5
6
5
12

<0.001
<0.001
<0.001
<0.001
0.002
0.003
0.003

0.008
0.008
0.008
0.008
0.008
0.008
0.008

Strain

Purine metabolism
Pyrimidine metabolism
Arginine and proline metabolism
Aminoacyl-tRNA biosynthesis

8
5
5
6

<0.001
0.001
0.002
0.002

0.007
0.007
0.007
0.007

Sex

Aminoacyl-tRNA biosynthesis

5

0.001

0.002

Strain

Aminoacyl-tRNA biosynthesis

6

0.001

0.004

Sex

Purine metabolism

9

<0.001

0.003

Strain

Purine metabolism
Pyrimidine metabolism
Pantothenate and CoA biosynthesis

17
13
5

<0.001
<0.001
0.002

0.003
0.003
0.003

Sex-by-Strain

Pyrimidine metabolism

4

0.001

0.002

Adipose

Muscle

Liver

Table 3. SNPs across mouse strains reveal genetic variation.
SNP Type per Mouse Strain
Intermediary Gene

Pathway Step

A/J

Enpp1

ATP → AMP

Cn, Cs

Ak7

AMP → ADP

Gdr

Guanine → Xanthine

U3

Nt5c3b

Adenosine → Inosine

Cn, Cs

Xdh

Xanthine → Uric acid

Guk1

GMP → GDP

C57BL/6J

FVB/NJ

NOD/ShiLtJ

Cn, Cs

U3, Cn, Cs
U3, Cn, Cs

U3

U3, Cn, Cs
U3, U5, Cn

U3, U5, Cn

U3, U5, Cn

Potential SNPs were identified using the Mouse Phenome Database SNP data retrieval utility (phenom.jax.org,
accessed on 22 February 2022). All SNPs are relative to C57BL/6J mice. Cn-non-synonymous SNP, Cs-synonymous
SNP, U5-UTR variant of the 50 UTR, U3-UTR variant of the 30 UTR.

2.5. Connecting Metabolic Profiles to Traits
Metabolic pathways are intertwined, and the levels of individual metabolites within a
given pathway are highly interdependent. To incorporate this behavior into the analyses,
weighted gene co-expression analysis (WGCNA) was implemented to identify clusters of
highly intercorrelated metabolites (modules) within each tissue. WGCNA was developed
to extract co-expressed sets of genes from transcriptomic datasets, but more recently
has been adopted for use with metabolomics data. Using this approach, a signed and
weighted network was constructed from metabolite abundance based on correlations, and
sets of highly interconnected metabolites were represented as modules. Modules were
then associated with phenotypes based on the correlation of the module’s representative
eigenmetabolite with each physiological trait. There were nine, nine, and eleven modules
identified within adipose, muscle, and liver, respectively (Supplemental Figure S3). Five
of the nine modules extracted from adipose tissue (yellow, turquoise, green, blue, and
black) were significantly correlated with adiposity, with four having inverse relationships
(Figure 6A). Four modules (yellow, pink, green, and black) were positively correlated
with activity level. Interestingly, three of these same modules (yellow, green, and black)

Metabolites 2022, 12, 337

9 of 16

were inversely related to adiposity, suggesting that the reciprocal relationship between
energy expenditure and fat accretion are reflected at the metabolite level in adipose tissue.
Similar relationships were observed in muscle (Figure 6B), with the blue and black modules
positively related to adiposity and inversely correlated to metabolic heat. Two modules
found in muscle (turquoise and brown) were positively correlated with both activity and
heat, reflecting the interrelationship between these traits. Four modules in liver (Figure 6C)
were associated with adiposity (two positively and two inversely), one of which (turquoise)
was also positively correlated with activity, heat, and VO2 . This module was inversely
Metabolites 2022, 12, x FOR PEER REVIEW
10 of 17
related to adiposity, further indicating that metabolite abundance in tissues reflects the
interrelationships between higher order metabolic traits.
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Pearson correlation. Correlation heatmaps for adipose (A), muscle (B), and liver (C) depict positive
Pearson correlation. Correlation heatmaps for adipose (A), muscle (B), and liver (C) depict positive
and negative relationships, with the p-value of each relationship overlayed onto the heatmap and
and negative relationships, with the p-value of each relationship overlayed onto the heatmap and
corrected using the Benjamini–Hochberg procedure.
corrected using the Benjamini–Hochberg procedure.

3. Discussion
Genetic background influences metabolic health, but the relationship between genetics and metabolism at the tissue level is poorly understood. Metabolites are a product of
cellular processes in the body and are therefore thought to be most closely related to phenotypes. We used untargeted metabolomics to investigate the effects of strain and sex on
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3. Discussion
Genetic background influences metabolic health, but the relationship between genetics
and metabolism at the tissue level is poorly understood. Metabolites are a product of
cellular processes in the body and are therefore thought to be most closely related to
phenotypes. We used untargeted metabolomics to investigate the effects of strain and sex
on the metabolomes of adipose tissue, liver, and skeletal muscle because of their central
roles in metabolism and energy expenditure. We also associated metabolites to body
composition and energy expenditure. Similar to individuals within a population, the
mouse strains chosen vary in terms of genetic backgrounds and potential for metabolic
disease, and in ways that differ between males and females.
We found that genetic background had a significant effect on the tissue metabolite
profiles, regardless of the tissue that was profiled. The majority of known metabolites
detected on our platform were significantly affected by strain in at least one tissue, based on
the ANOVA results. Likewise, PLS-DA discriminated strains based on metabolite profiles,
with A/J and C57BL/6J each distinctly separated from FVB/N and NOD mice. Our
findings support the concept of individual “metabotypes” (metabolic phenotypes), a term
used to describe the variation in metabolite profiles that exists between individuals [16].
More specifically, our results indicate that genetic variation is likely a major determinant
of metabotypes. Metabotypes have been shown to be surprisingly stable across various
physiological states and over time [17]. In a longitudinal study of 818 individuals, 95%
of participants showed a high degree (>70%) of metabotype conservation over a sevenyear period [18]. Understanding the basis for a metabotype is highly relevant to the
emerging fields of precision nutrition and personalized medicine, which seek to tailor
diets or therapeutic interventions to the individual [19,20]. Distinct metabotypes detected
in blood or urine from clinical populations have been associated with the incidence and
progression of various diseases such as cardiovascular disease and diabetes [17,21]. In
addition to disease risk, metabotypes have been associated with interindividual differences
in fundamental physiological traits. Chu and coworkers recently applied the metabolome
profiling of blood to a cohort of individuals that had been richly phenotyped for baseline
immune parameters [5]. Distinct metabolite profiles were associated with various cytokine
measures and explained up to 30% of the variation in cytokine responses that existed
between individuals. Metabotypes have also been used to design diets that manipulate
the post-prandial glycemic response to a meal in predictable directions, demonstrating the
application of metabolic phenotypes to precision nutrition [7].
The integration of metabolomics in genome-wide association studies (GWAS) supports the concept that genetic background influences metabolite profiles. Loci linked to
metabolite profiles (mQTLS) have been identified in numerous studies [5]. Further, a recent
metanalysis of GWAS indicated that heritability estimates approach 50% for some classes
of metabolites [3]. While these various studies point to a role for genetic background, it
remains difficult to uncouple the impact of polymorphic variation from other non-genetic
sources of variation that exist in humans [22]. Large-scale studies allow the confounding effects of known variation in diet, age, environment, and lifestyle to be incorporated
into models. However, the impact of variation in the gut microbiota, which contributes
metabolites to the circulatory system, is difficult to account for, but is likely to influence
metabolite profiles in body fluids, which are typically the target of metabolome profiling
in humans. In contrast, our data are derived directly from tissues, which are less likely to
contain metabolites produced by the microbiota. In addition, the ability to profile multiple
individuals within a strain provided us with a level of genetic replication that, outside of
twin studies, is not available in human studies. Our experimental design also used mice of
the same age, which allowed us to control for interactions between sex and age that have
been described in other metabolomics studies [23].
Nearly a third (30 of 103) of metabolites in liver that were influenced by strain are
involved in purine and pyrimidine metabolism. Purines and pyrimidines are central to
the function of all cells as subunits of nucleic acids. In addition, these nucleotides and
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their derivatives carry energy, allosterically control enzymatic reactions, mediate intraand intercellular signaling pathways, and participate in the control of cellular metabolism.
Purine metabolism, in particular, is linked to pathways that govern cellular energy allocation through its relationship to AMPK (50 AMP-activated protein kinase), a kinase that is
allosterically activated by a rise in AMP:ATP. AMPK mediates the response to an energy
deficit by activating the pathways that generate ATP and inhibiting those that consume ATP.
AMPK can also be activated by the ZMP (5-aminoimidazole-4-carboxamide ribonucleotide),
an intermediate in de novo purine synthesis that acts as an AMP mimetic. Recent studies
have shown that altering purine metabolism in ways that increase ZMP activates AMPK
and elicits the same types of metabolic changes, such as the increased oxidation of fatty
acids, that result from an increase in AMP. Our assessment of SNPs identified several
potential variants that may contribute to genetic differences in nucleotide metabolism
between the inbred strains used here. In general, our data are consistent with a recent study
of the tissue metabolomes of three inbred strains, in which purine metabolism was also
identified as a pathway in the differentiated mice of different genetic backgrounds [12,24].
In conclusion, we have used the replicability of inbred strains and the control provided
by laboratory husbandry to compare the effects of genetic background, sex, and their
interactions on the metabolomes of key metabolic tissues. We provide evidence that genetic
background, more so than sex, significantly influences tissue metabolomes, particularly in
liver. Future studies are needed to determine whether and how these underlying differences
in metabolism contribute to the risks of various metabolic diseases that are represented
by this collection of inbred strains. Our data further support the concept of individual
metabotypes, which has important implications for the emerging field of precision health.
4. Materials and Methods
4.1. Animals and Diets
All husbandry and experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of North Carolina. Four-week-old C57BL/6J
mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). The mice were
allowed to acclimate for 14 days and consumed a standard mouse chow (PicoLab Mouse
Diet 20, LabDiet, St. Louis, MO, USA) during this period. At 42 days of age, five male and
five female mice from each strain were switched to a marginally lower protein standard
chow diet (19% protein) and fed ad libitum. The mice were maintained on a 12 h light/dark
cycle throughout the study. At age 18 weeks, after 12 weeks on the diets, the mice were
housed in Phenomaster metabolic chambers (TSE Systems, Inc., Chesterfield, MO, USA) for
48 h for the measurement of metabolic rate and activity. The chambers measured respiratory
exchange rate (RER), volume of oxygen (VO2 ), and heat output via heat dissipation, and
activity level by laser detection through the ActiMot2 module. Activity levels measured
voluntary movement of the mouse in the x and y plane by quantifying horizontal and
vertical beam breaks. The mice were euthanized at 28 weeks of age by CO2 asphyxiation.
Perigonadal adipose tissue was dissected and weighed as a measure of adiposity. Samples of adipose tissue, the left lobe of the liver, and the vastus medialis, vastus lateralis,
and rectus femoris muscle were snap-frozen in liquid nitrogen and stored at −80 ◦ C for
metabolomics analysis.
4.2. Metabolite Extraction from Tissues
The frozen tissue samples were pulverized under liquid nitrogen and approximately
0.025 g of tissue was added to a 2 mL Eppendorf tube containing pre-chilled methanol
(1.3 mL). Samples were extracted using the method described in [25]. Internal standard
(60 µL of a 13 C-labeled E. coli metabolite pool) was added to each sample.
4.3. Liquid Chromatography Mass Spectrometry
The samples, kept at 4 ◦ C, were placed in an autosampler tray. A total of 10 µL from
each sample was injected through a Synergi 2.5 micron Hydro-RP 100, 100 × 2.00 mm
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LC column (Phenomenex, Torrance, CA, USA) kept at 25 ◦ C. The mass spectrometer (MS)
was run in full scan mode, with negative ionization mode, using a method adapted from
Lu et al. [26]. The eluent entered the MS via an electrospray ionization source attached to
a Thermo Scientific Exactive Plus Orbitrap MS (Waltham, MA, USA) through a 0.1 mm
internal diameter fused silica capillary tube. The samples were run with a spray voltage of
3 kV. The nitrogen sheath gas was set to a flow rate of 10 psi, with a capillary temperature
of 320 ◦ C. The AGC target was set to 3 × 106 . The samples were analyzed with a resolution
of 140,000. A scan window of 85 to 800 m/z (mass-to-charge) was used from 0 to 9 min, and
a window of 110 to 1000 m/z from 9 to 25 min. Solvent A consisted of 97:3 water:methanol,
10 mM tributylamine, and 15 mM acetic acid. Solvent B was methanol. The gradient from
0 to 5 min was 0% Solvent B, from 5 to 13 min was 20% Solvent B, from 13 to 15.5 min
was 55% Solvent B, from 15.5 to 19 min was 95% Solvent B, and from 19 to 25 min was 0%
Solvent B, with a flow rate of 200 µL/min.
4.4. Generation of 13 C-Labeled E. coli
E. coli metabolites were labeled with 13 C and extracted using a method adapted from
Bennett et al. [27,28] and described in [25].
4.5. Metabolomics Data Processing
Raw spectra files generated by Xcalibur were converted to mzML, an open-source format, using msConvert [29]. An open-source data analyzer for metabolomics, MAVEN [30,31]
(Princeton University) was used to retention time correct the total ion chromatograms based
on peaks picked from the extracted ion chromatograms for each sample. Metabolite identities were assigned by matching mass-to-charge (m/z) (within ±5 ppm) and retention
time (r.t.) (within ±30 s) to values measured from purified standard compounds that were
used to construct a database for validated metabolites. The peak quality for all identified
metabolites was checked manually, and metabolite abundance was quantitated as ion
counts that were integrated from the area under each peak. Unidentified metabolites were
chosen based on a peak-picking algorithm provided in MAVEN. These compounds were
named as m/z:r.t. pairs, and the peak area was then integrated as described for the identified
compounds using an algorithm described in [25]. Three samples (one each: FVB female,
FVB male, NOD female) were removed from further analyses due to poor peak quality.
The final sample sizes for metabolomics analyses were N = 5 for both sexes of A/J and C57,
and for NOD males, with N = 4 for FVB (male and female) and for NOD male.
4.6. Use of 13 C-Labelled E. coli Cellular Extracts as an Internal Standard
Prior to the use of diluted 13 C-labeled E. coli as internal standards in the samples,
triplicate aliquots of the labeled extracts were analyzed using the LC–MS metabolomics
method [26]. The resulting data were then processed identically to the samples. Since the
13 C-labeled E. coli internal standard was used as a normalization technique, verification
that non-significant amounts of 12 C-label remained within the samples was performed for
the identified metabolites. Unlabeled metabolites were matched to their corresponding 13 Clabeled internal standard if detected, or to a 13 C-labeled standard of the same compound
class if no stable isotope-labeled standard was detected (e.g., an amino acid with no exact
standard match would be matched to a 13 C-labeled metabolite with class type amino acid).
The same 13 C-labeled metabolite for a particular class type was used for the normalization
of all metabolites of the same class type missing an exact 13 C-label metabolite match (i.e.,
13 C-labeled tyrosine was used for all amino acids missing a 13 C-labeled match). Class types
were identified using the Human Metabolome Database (HMDB) [32–34] using the class
types listed under each metabolite identified in the HMDB. The ion intensities for each
unlabeled metabolite were normalized to those of the appropriate 13 C-labeled standard in
order to correct for instrumental variability among the sample analyses.
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4.7. Statistical Analysis
All statistical analyses were performed in the language R (3.1.0 and 3.2.2) [35]. An
ANOVA model was used to identify the significant effects of diet, sex, and sex-by-diet
interaction on physiological traits. A significant F-test for the effects of strain, sex, or their
interaction was followed by a Tukey’s Honest Significant Difference (HSD) test, used for post
hoc testing. The significance for physiological traits was based on raw p-values (p < 0.05).
The same ANOVA model was used to identify the significant effects of strain, sex,
and sex-by-strain interaction on metabolites, controlling for false discovery rate (FDR) to
account for multiple testing (described in further detail below). Metabolite peak area data
files were read into R using the package XLConnect [36]. Metabolites that were missing
more than 10% of their sample measurements were removed from the analysis in order to
obtain the most complete dataset possible. Missing values in the remaining metabolites
were imputed using k-nearest numbers (k = 10) from the function impute [37]. Prior to
the statistical analyses, a linear model was created for each metabolite using the terms sex,
strain, sex*strain, tissue weight, and internal standard (Equation (1)):
Metabolite = sex + strain + sex*strain + tissue weight + internal standard

(1)

This linear model was performed prior to formal statistical analysis to determine the
coefficients for tissue weight and internal standard, which were utilized in Equation (2) to
obtain metabolite abundances adjusted for tissue weight and internal standard.
Coefficients for the terms for tissue weight and internal standard were used to adjust
metabolite abundance for technical variation using Equation (2):
Adjusted metabolite = metabolite + tissue weight coefficient (mean tissue weight − tissue weight) +
internal standard coefficient (mean internal standard − internal standard)

(2)

Adjusted metabolites were pareto scaled across all mice for each metabolite using
the package MetabolAnalyze [38], normalized to the median across all metabolites for
each mouse, and cube root transformed. Normalized metabolite values were analyzed for
effects of sex, strain, and sex*strain. Data were assessed for normality using Q-Q plots,
residuals, and the Shapiro–Wilk test. The false discovery rate for ANOVA and correlation
analyses was set to 5% using the method of Benjamin–Hochberg [39]. FDR-adjusted
p-values were estimated by calculating the q-value. Venn diagrams were created using the
package VennDiagram [40].
4.8. Partial Least Squares Discriminant Analysis
Partial least squares discriminant analysis (PLS-DA) was used to characterize the strain,
sex, and sex-by-strain effects on the tissue metabolome using identified and unidentified
metabolites. The PLS-DA algorithm was implemented using the package DiscriMiner [41].
Scores plots with Hotelling’s T2 ellipses were created using the packages plyr and Car [42,43].
External cross-validation was used to assess the model performance and to reduce overfitting using 1000 permutations (Supplemental Figure S1). Two-thirds of the mice were
randomly assigned as the training set, while the remaining mice were used as a test set, to
determine the model performance. The assessment of the model was based on the model’s
ability to correctly identify the treatment assignment of the new mice in the test set, based
on the mice from the beginning training set.
4.9. Correlation Analysis
Associations between the physiological measurements and the metabolite measurements across tissues were assessed using Pearson correlation from the package Hmisc [44]
and the package R.Utils [45]. Correlation p-values were FDR-adjusted using the Benjamini–
Hochberg procedure. Correlations were visualized using the Cytoscape app MetScape [46].
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4.10. Functional Pathway Analysis
Overrepresentation pathway analysis for the identified metabolites was performed
using MetaboAnalyst [47]. KEGG IDs were input and compared against the Mus musculus
KEGG reference metabolome. The statistical significance of pathway overrepresentation
was evaluated using a Fisher’s exact test. The p-values were adjusted using the Benjamini–
Hochberg procedure. Pathway topology was performed using relative-between centrality.
4.11. Weighted Gene Co-Expression Network Analysis
To identify potential metabolite networks, weighted gene co-expression network analysis
(WGCNA) was performed using the ‘WGCNA’ R package [48]. The soft-thresholding power
was chosen so that the scale-free topology correlation hits 9. Soft-thresholding powers chosen
for adipose, muscle, and liver were 9, 8, and 5, respectively (Supplemental Figure S2). Dynamic tree cutting was used to cluster the metabolites and generate modules with a minimum
of five metabolites in each module. Networks were identified using identified metabolites.
ANOVA was performed for each module using the linear model:
Module = sex + strain + sex*strain

(3)

to determine the effects of the sex, strain, or sex-by-strain interaction on each module.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/metabo12040337/s1, Figure S1: Density and frequency plots of PLS-DA permutations,
Figure S2: Choosing soft-threshold power, Figure S3: Topological overlap matrix and module
bar plots, Table S1: Variable importance projections for adipose partial least squares discriminant
analysis (Excel file), Table S2: Variable importance projections for skeletal muscle partial least squares
discriminant analysis (Excel file), Table S3: Variable importance projections for liver partial least
squares discriminant analysis (Excel file).
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